275 filings
Page 2 of 14
8-K
q6avby4bs
29 Feb 24
Regulation FD Disclosure
8:30am
8-K
lg8oya 3ndobm
22 Feb 24
Regulation FD Disclosure
9:30am
8-K
mnfcfs
15 Feb 24
Regulation FD Disclosure
9:15am
8-K
utsdbd43asu
14 Feb 24
Regulation FD Disclosure
4:36pm
8-K
2965x9dp8blgmfn ot
14 Feb 24
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
53y70p1 833x9gqhmhs
24 Jan 24
Regulation FD Disclosure
8:50am
8-K
6e99vbag0tfg rn
5 Jan 24
Departure of Directors or Certain Officers
5:14pm
8-K
nc6h8vx q4
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
wwhpph5w004
18 Dec 23
Regulation FD Disclosure
8:55am
8-K
mpyu 0n1acr
11 Dec 23
Regulation FD Disclosure
8:55am
8-K
6mjiq2u3qhcwarw1di
11 Dec 23
Moleculin Presents Positive Interim Data from Phase 1B/2 Clinical Trial in AML at Meeting with KOL’s in Conjunction with ASH Annual Meeting
8:50am
8-K
45k1zamb
20 Nov 23
Regulation FD Disclosure
9:15am
8-K
7r96 y13zx6
13 Nov 23
Regulation FD Disclosure
8:30am
8-K
4vfezoul72i5mbj 57
13 Nov 23
Regulation FD Disclosure
8:05am
8-K
34hppg7kxva8lf2i ow
13 Nov 23
Moleculin Reports Third Quarter 2023 Financial Results
8:00am
8-K
q6o1yn4l
7 Nov 23
Regulation FD Disclosure
8:45am
8-K
0tyeubec gew
6 Nov 23
Regulation FD Disclosure
8:35am
8-K
23ari ehj0b6k2eq6
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
51wcz1 f9znyj05
17 Oct 23
Regulation FD Disclosure
9:00am
8-K
wuynv5n0b7 umm71
6 Oct 23
Submission of Matters to a Vote of Security Holders
5:15pm